Results 171 to 180 of about 76,496 (274)

Ribavirin plus interferon daily or thrice weekly in chronic hepatitis C genotype 4 [PDF]

, 2000
Ayman Y. Abdel Rahim, Mohsen Salama, Salah El-Dirini, Baher Badawy   +3 more
openalex   +1 more source

Repurposing of the nucleoside analogs for influenza. [PDF]

Comput Struct Biotechnol J
Mee-Udorn P, Narkpuk J, Jaru-Ampornpan P, Hongeng S, Uengwetwanit T, Srimongkolpithak N.   +5 more
europepmc   +1 more source

Interferon plus ribavirin for chronic hepatitis C in HIV-infected patients

, 2000
Vincent Soriano, Rafael Rodrı́guez-Rosado, Mayte Pérez‐Olmeda, Míriam Romero, Javier García–Samaniego   +4 more
openalex   +1 more source

Ribavirin

, 2016
openaire   +1 more source

Can Adoptive Immunotherapy With Hepatitis E Virus (HEV)-Specific T Cells Address the Unmet Need in Refractory Chronic HEV Infection? [PDF]

Open Forum Infect Dis
Lampejo T.
europepmc   +1 more source

TREATMENT OF RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION WITH INTERFERON ALFA 2B AND RIBAVIRIN.

, 2000
Fausto Zamboni, A Franchello, Bruna Lavezzo, Paolo Strignano, M. Schellino, Mario Rizzetto, Mauro Salizzoni   +6 more
openalex   +1 more source

Global distribution and temporal analysis of R70Q/H oncogenic mutations in hepatitis C virus subtype 1b core protein. [PDF]

Front Cell Infect Microbiol
Nunes GTM, Araujo NM.
europepmc   +1 more source

Differential thrombopoietin response to treatment-induced thrombocytopenia: IFN VS. IFN-ribavirin VS. PEG-IFN

, 2000
Anna Kreil, Markus Peck‐Radosavljevic, Harald Hofer, Martina Wichlas, Alfred Gangl, Peter Ferenci   +5 more
openalex   +1 more source

Contribution of critical amino acid residues in the RNA-dependent RNA polymerase to the replication fidelity and viral ribavirin sensitivity of porcine reproductive and respiratory syndrome virus. [PDF]

Vet Res
Zhang X, Yang Z, Zhang Z, Wang Z, Zhao Y, Yang T, Gong J, Feng K, He J, Zheng Q, Hou J, Li P.   +11 more
europepmc   +1 more source

Low dose ribavirin for six months plus interferon 5 MU TIW for 1 year is effective in the treatment of hepatitis C patients who were initially either relapsers or non-responders to interferon monotherapy

, 2000
David Bernstein, Lennox J. Jeffers, Gerard Lake-Bakaar   +2 more
openalex   +1 more source